Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Azacitidine Dr Reddy’s |
| Active Ingredient: | Azacitidine 100mg |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Dr Reddy’s New Zealand Limited |
| Manufacturer: | Dr Reddy’s Laboratories Limited, Visakhapatnam, India |
| Product: | Melotin |
| Active Ingredient: | Melatonin 2mg |
| Dosage Form: | Modified release tablet |
| New Zealand Sponsor: | Arrotex Pharmaceuticals (NZ) Limited |
| Manufacturers: | Oman Pharmaceutical Products Company LLC, Salalah, Oman Gracure Pharmaceuticals Limited, Bhiwadi, India |
| Product: | Neosynephrine |
| Active Ingredient: | Phenylephrine hydrochloride 10mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Hospira Inc, North Carolina, United States of America |
Dated this 22nd day of March 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).